AAPL294.65+0.35 (+0.12%) ▲|ABBV235.29+0.53 (+0.22%) ▲|ABT90.62+0.09 (+0.10%) ▲|ACN130.29+3.28 (+2.58%) ▲|ADBE197.57+0.14 (+0.07%) ▲|AMAT576.53-9.36 (-1.60%) ▼|AMD513.45-6.40 (-1.23%) ▼|AMGN352.48+5.47 (+1.57%) ▲|AMT175.71-3.67 (-2.05%) ▼|AMZN235.54+1.43 (+0.61%) ▲|AVGO379.23-0.93 (-0.24%) ▼|AXP341.87+4.09 (+1.21%) ▲|BA219.37+2.66 (+1.23%) ▲|BAC57.72-0.20 (-0.34%) ▼|BKNG182.88+13.94 (+8.25%) ▲|BLK979.37-35.97 (-3.54%) ▼|BMY55.15-0.39 (-0.69%) ▼|BNY143.76-3.53 (-2.40%) ▼|BRK-B495.50+2.69 (+0.54%) ▲|C144.05-0.93 (-0.64%) ▼|CAT986.09+1.85 (+0.19%) ▲|CL92.01+0.58 (+0.63%) ▲|CMCSA22.64-0.17 (-0.72%) ▼|COF200.08+2.27 (+1.15%) ▲|COP106.76-3.21 (-2.92%) ▼|COST960.39+2.71 (+0.28%) ▲|CRM153.20-0.23 (-0.15%) ▼|CSCO119.21-1.94 (-1.60%) ▼|CVS102.08+0.51 (+0.50%) ▲|CVX171.54-4.44 (-2.52%) ▼|DE604.97+13.03 (+2.20%) ▲|DHR188.38+9.41 (+5.26%) ▲|DIS101.29-2.24 (-2.16%) ▼|DUK126.03+0.98 (+0.78%) ▲|EMR141.03-2.11 (-1.47%) ▼|FDX315.83-1.42 (-0.45%) ▼|GD344.59-5.75 (-1.64%) ▼|GE364.03+7.56 (+2.12%) ▲|GEV1,047.61+12.63 (+1.22%) ▲|GILD125.67+0.62 (+0.49%) ▲|GM79.16+0.21 (+0.27%) ▲|GOOG344.09-1.99 (-0.58%) ▼|GOOGL344.92-1.17 (-0.34%) ▼|GS1,075.17-19.28 (-1.76%) ▼|HD340.59+16.14 (+4.97%) ▲|HON226.97+4.60 (+2.07%) ▲|IBM263.00-1.94 (-0.73%) ▼|INTC130.46-1.83 (-1.38%) ▼|INTU263.87+5.82 (+2.26%) ▲|ISRG402.54-0.64 (-0.16%) ▼|JNJ240.13+1.05 (+0.44%) ▲|JPM333.82-0.32 (-0.10%) ▼|KO80.75+0.44 (+0.54%) ▲|LIN515.95+3.69 (+0.72%) ▲|LLY1,111.82+4.74 (+0.43%) ▲|LMT493.31-10.36 (-2.06%) ▼|LOW220.86+7.32 (+3.43%) ▲|LRCX367.32-4.01 (-1.08%) ▼|MA494.63+6.56 (+1.34%) ▲|MCD274.48+2.82 (+1.04%) ▲|MDLZ61.90+0.84 (+1.37%) ▲|MDT80.37-0.27 (-0.33%) ▼|META557.65-4.55 (-0.81%) ▼|MMM165.83+3.99 (+2.47%) ▲|MO71.80+0.19 (+0.26%) ▲|MRK120.77+1.17 (+0.98%) ▲|MS220.38-5.66 (-2.50%) ▼|MSFT368.27-5.67 (-1.52%) ▼|MU1,027.39-24.38 (-2.32%) ▼|NEE87.28+0.85 (+0.98%) ▲|NFLX72.16-0.67 (-0.91%) ▼|NKE41.84-0.55 (-1.29%) ▼|NOW93.68-2.26 (-2.36%) ▼|NVDA197.58-2.42 (-1.21%) ▼|ORCL156.40-8.77 (-5.31%) ▼|PEP142.19+0.14 (+0.10%) ▲|PFE24.05-0.68 (-2.73%) ▼|PG152.31+1.45 (+0.96%) ▲|PLTR113.65-3.05 (-2.61%) ▼|PM178.10-0.59 (-0.33%) ▼|QCOM194.61-9.52 (-4.66%) ▼|RTX185.47-0.92 (-0.49%) ▼|SBUX104.00+2.95 (+2.92%) ▲|SCHW91.57-1.60 (-1.72%) ▼|SO95.48+0.55 (+0.57%) ▲|SPG220.91+4.17 (+1.92%) ▲|T22.38-0.43 (-1.88%) ▼|TMO490.69+21.34 (+4.55%) ▲|TMUS181.92-2.65 (-1.44%) ▼|TSLA375.74-5.87 (-1.54%) ▼|TXN303.66-0.70 (-0.23%) ▼|UBER74.20+4.53 (+6.50%) ▲|UNH405.93-3.32 (-0.81%) ▼|UNP259.90+1.29 (+0.50%) ▲|UPS105.55-0.28 (-0.26%) ▼|USB60.11+0.06 (+0.09%) ▲|V332.07+3.59 (+1.09%) ▲|VZ45.67-1.07 (-2.28%) ▼|WFC84.06-0.07 (-0.08%) ▼|WMT119.24-0.18 (-0.15%) ▼|XOM136.32-3.41 (-2.44%) ▼|AAPL294.65+0.35 (+0.12%) ▲|ABBV235.29+0.53 (+0.22%) ▲|ABT90.62+0.09 (+0.10%) ▲|ACN130.29+3.28 (+2.58%) ▲|ADBE197.57+0.14 (+0.07%) ▲|AMAT576.53-9.36 (-1.60%) ▼|AMD513.45-6.40 (-1.23%) ▼|AMGN352.48+5.47 (+1.57%) ▲|AMT175.71-3.67 (-2.05%) ▼|AMZN235.54+1.43 (+0.61%) ▲|AVGO379.23-0.93 (-0.24%) ▼|AXP341.87+4.09 (+1.21%) ▲|BA219.37+2.66 (+1.23%) ▲|BAC57.72-0.20 (-0.34%) ▼|BKNG182.88+13.94 (+8.25%) ▲|BLK979.37-35.97 (-3.54%) ▼|BMY55.15-0.39 (-0.69%) ▼|BNY143.76-3.53 (-2.40%) ▼|BRK-B495.50+2.69 (+0.54%) ▲|C144.05-0.93 (-0.64%) ▼|CAT986.09+1.85 (+0.19%) ▲|CL92.01+0.58 (+0.63%) ▲|CMCSA22.64-0.17 (-0.72%) ▼|COF200.08+2.27 (+1.15%) ▲|COP106.76-3.21 (-2.92%) ▼|COST960.39+2.71 (+0.28%) ▲|CRM153.20-0.23 (-0.15%) ▼|CSCO119.21-1.94 (-1.60%) ▼|CVS102.08+0.51 (+0.50%) ▲|CVX171.54-4.44 (-2.52%) ▼|DE604.97+13.03 (+2.20%) ▲|DHR188.38+9.41 (+5.26%) ▲|DIS101.29-2.24 (-2.16%) ▼|DUK126.03+0.98 (+0.78%) ▲|EMR141.03-2.11 (-1.47%) ▼|FDX315.83-1.42 (-0.45%) ▼|GD344.59-5.75 (-1.64%) ▼|GE364.03+7.56 (+2.12%) ▲|GEV1,047.61+12.63 (+1.22%) ▲|GILD125.67+0.62 (+0.49%) ▲|GM79.16+0.21 (+0.27%) ▲|GOOG344.09-1.99 (-0.58%) ▼|GOOGL344.92-1.17 (-0.34%) ▼|GS1,075.17-19.28 (-1.76%) ▼|HD340.59+16.14 (+4.97%) ▲|HON226.97+4.60 (+2.07%) ▲|IBM263.00-1.94 (-0.73%) ▼|INTC130.46-1.83 (-1.38%) ▼|INTU263.87+5.82 (+2.26%) ▲|ISRG402.54-0.64 (-0.16%) ▼|JNJ240.13+1.05 (+0.44%) ▲|JPM333.82-0.32 (-0.10%) ▼|KO80.75+0.44 (+0.54%) ▲|LIN515.95+3.69 (+0.72%) ▲|LLY1,111.82+4.74 (+0.43%) ▲|LMT493.31-10.36 (-2.06%) ▼|LOW220.86+7.32 (+3.43%) ▲|LRCX367.32-4.01 (-1.08%) ▼|MA494.63+6.56 (+1.34%) ▲|MCD274.48+2.82 (+1.04%) ▲|MDLZ61.90+0.84 (+1.37%) ▲|MDT80.37-0.27 (-0.33%) ▼|META557.65-4.55 (-0.81%) ▼|MMM165.83+3.99 (+2.47%) ▲|MO71.80+0.19 (+0.26%) ▲|MRK120.77+1.17 (+0.98%) ▲|MS220.38-5.66 (-2.50%) ▼|MSFT368.27-5.67 (-1.52%) ▼|MU1,027.39-24.38 (-2.32%) ▼|NEE87.28+0.85 (+0.98%) ▲|NFLX72.16-0.67 (-0.91%) ▼|NKE41.84-0.55 (-1.29%) ▼|NOW93.68-2.26 (-2.36%) ▼|NVDA197.58-2.42 (-1.21%) ▼|ORCL156.40-8.77 (-5.31%) ▼|PEP142.19+0.14 (+0.10%) ▲|PFE24.05-0.68 (-2.73%) ▼|PG152.31+1.45 (+0.96%) ▲|PLTR113.65-3.05 (-2.61%) ▼|PM178.10-0.59 (-0.33%) ▼|QCOM194.61-9.52 (-4.66%) ▼|RTX185.47-0.92 (-0.49%) ▼|SBUX104.00+2.95 (+2.92%) ▲|SCHW91.57-1.60 (-1.72%) ▼|SO95.48+0.55 (+0.57%) ▲|SPG220.91+4.17 (+1.92%) ▲|T22.38-0.43 (-1.88%) ▼|TMO490.69+21.34 (+4.55%) ▲|TMUS181.92-2.65 (-1.44%) ▼|TSLA375.74-5.87 (-1.54%) ▼|TXN303.66-0.70 (-0.23%) ▼|UBER74.20+4.53 (+6.50%) ▲|UNH405.93-3.32 (-0.81%) ▼|UNP259.90+1.29 (+0.50%) ▲|UPS105.55-0.28 (-0.26%) ▼|USB60.11+0.06 (+0.09%) ▲|V332.07+3.59 (+1.09%) ▲|VZ45.67-1.07 (-2.28%) ▼|WFC84.06-0.07 (-0.08%) ▼|WMT119.24-0.18 (-0.15%) ▼|XOM136.32-3.41 (-2.44%) ▼|
27.5 C
New York
Wednesday, June 24, 2026

Tag: pharmaceutical

newssourceFORcompanyinformationcontent1marketreleases

4 Emerging Graft versus Host Disease Therapies That Could Change the Treatment Landscape | DelveInsight

Key companies, such as CSL Behring, Equillium, Biocon, and medac, are advancing their assets through late-stage graft versus host disease clinical trials, driving innovation...

Cancer Pain Market Set to Transform by 2034 Due to Launch of Breakthrough Therapies | DelveInsight

According to DelveInsight's analysis, the growth of the cancer pain market is expected to be mainly driven by increasing incidence and advances in disease...

[Latest] Global Pharmaceutical Glass Packaging Market Size/Share Worth USD 49.20 Billion by 2034 at a 7.87% CAGR: Business Research Industry (Analysis, Outlook, Leaders, Report,...

[220+ Pages Latest Report] According to a market research study published by Business Research Industry, the demand analysis of Global Pharmaceutical Glass Packaging Market size & share revenue was valued at approximately USD 23.36 Billion in 2024 and is expected to reach USD 24.87 Billion in 2025 and is expected to reach around USD 49.20 Billion by 2034, at a CAGR of 7.87% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Corning Incorporated, Nipro Corporation, SGD S.A., Stoelzle Oberglas GmbH, Bormioli Pharma S.p.A., West Pharmaceutical Services Inc., Schott AG, Gerresheimer AG, Shandong Medicinal Glass Co. Ltd., Beatson Clark, Ardagh Group S.A, Arab Pharmaceutical Glass Co., Piramal Enterprises Ltd., Şişecam Group, Owens-Illinois Inc., DWK Life sciences, and others. 
[220+ Pages Latest Report] According to a market research study published by Business Research Industry, the demand analysis of Global Pharmaceutical Glass Packaging Market size & share revenue was valued at approximately USD 23.36 Billion in 2024 and is expected to reach USD 24.87 Billion in 2025 and is expected to reach around USD 49.20 Billion by 2034, at a CAGR of 7.87% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Corning Incorporated, Nipro Corporation, SGD S.A., Stoelzle Oberglas GmbH, Bormioli Pharma S.p.A., West Pharmaceutical Services Inc., Schott AG, Gerresheimer AG, Shandong Medicinal Glass Co. Ltd., Beatson Clark, Ardagh Group S.A, Arab Pharmaceutical Glass Co., Piramal Enterprises Ltd., Şişecam Group, Owens-Illinois Inc., DWK Life sciences, and others.

Daewoong Pharmaceutical Launches NABOTA in Qatar, Expands Presence in High-Potential GCC Aesthetic Market

DOHA, Qatar, June 12, 2025  /PRNewswire/ -- Daewoong Pharmaceutical has officially launched its high-purity, high-quality botulinum toxin, NABOTA, in Qatar—further reinforcing its strategy to...

Dignify Therapeutics Announces Jeff Welch as Chief Operating Officer

RESEARCH TRIANGLE PARK, N.C., June 12, 2025 /PRNewswire/ -- Dignify Therapeutics (Dignify), a pharmaceutical and medical device development company focused on restoring bowel and bladder...

Specialised Therapeutics Expands Partnership with Incyte to Include Two Additional Therapies for Hard-to-Treat Conditions

SINGAPORE, June 12, 2025 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce the expansion of its existing supply and distribution agreement...

LabConnect Selects Deloitte to Streamline Financial and Business Operations

JOHNSON CITY, Tenn., June 12, 2025 /PRNewswire/ -- LabConnect, a leading provider of global central laboratory and support services for clinical trials, has selected...

Pharmaceutical Industry Calls on G7 to Prioritize Innovation as Strategic Pillar for Health, Growth and Security

GENEVA and OTTAWA, ON, June 12, 2025 /CNW/ - Ahead of the upcoming G7 Leaders' Summit, the global pharmaceutical industry, represented by the International...

Black Buffalo Strengthens Leadership with Kit Dietz’s Board Re-Election and Viv Penninti’s Appointment as Senior Advisor

CHICAGO, June 12, 2025 /PRNewswire/ -- Black Buffalo Inc., the leading alternative to traditional smokeless tobacco, proudly announces the re-election of Kit Dietz to...

Rebel Medicine Announces Series A Financing and Investigational New Drug (IND) Application Opening to Advance Non‑Opioid Pain Therapeutic into Clinical Development

SALT LAKE CITY, June 12, 2025 /PRNewswire/ -- Rebel Medicine Inc, a clinical‑stage biotechnology company developing innovative drug delivery systems and non‑opioid pain therapeutics...

Vascarta Receives FDA Orphan Drug Designation for Vasceptor® in the Treatment of Sickle Cell Disease

SUMMIT, N.J., June 12, 2025 /PRNewswire/ -- Vascarta Inc., a biopharmaceutical company committed to advancing innovative therapies for underserved patient populations, announced today that...

Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics

Vancouver, Canada, June 12, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics

Hoth Therapeutics Secures Japanese Patent for Breakthrough HT-KIT Platform Targeting Mast Cell Diseases

Protection through 2039, ensuring long-term commercial exclusivity. NEW YORK, June 12, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative...

Standard Industries Announces Molecule.one as Winner of $1 Million AI Challenge

Novel AI Application to Accelerate the Development and Production of Pharmaceuticals NEW YORK, June 12, 2025 /PRNewswire/ -- Standard Industries ("Standard"), a privately-held global industrial...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPharmaceutical

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers